BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37727010)

  • 1. Skeletal muscle adaptations in patients with lung cancer: Longitudinal observations from the whole body to cellular level.
    Snoke DB; Bellefleur E; Rehman HT; Carson JA; Poynter ME; Dittus KL; Toth MJ
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2579-2590. PubMed ID: 37727010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.
    van de Worp WRPH; Schols AMWJ; Dingemans AC; Op den Kamp CMH; Degens JHRJ; Kelders MCJM; Coort S; Woodruff HC; Kratassiouk G; Harel-Bellan A; Theys J; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):452-463. PubMed ID: 31828982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of total knee arthroplasty on skeletal muscle structure and function at the cellular, organellar, and molecular levels.
    Toth MJ; Savage PD; Voigt TB; Anair BM; Bunn JY; Smith IB; Tourville TW; Blankstein M; Stevens-Lapsley J; Nelms NJ
    J Appl Physiol (1985); 2022 Sep; 133(3):647-660. PubMed ID: 35900327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer.
    Tobberup R; Rasmussen HH; Holst M; Jensen NA; Falkmer UG; Bøgsted M; Delekta AM; Carus A
    Clin Nutr ESPEN; 2019 Dec; 34():94-100. PubMed ID: 31677719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival.
    Kiss N; Beraldo J; Everitt S
    Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
    Degens JHRJ; Sanders KJC; de Jong EEC; Groen HJM; Smit EF; Aerts JG; Schols AMWJ; Dingemans AC
    Lung Cancer; 2019 Jul; 133():130-135. PubMed ID: 31200819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer.
    Stene GB; Helbostad JL; Amundsen T; Sørhaug S; Hjelde H; Kaasa S; Grønberg BH
    Acta Oncol; 2015 Mar; 54(3):340-8. PubMed ID: 25225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin heavy-chain isoform distribution, fibre-type composition and fibre size in skeletal muscle of patients on haemodialysis.
    Molsted S; Eidemak I; Sorensen HT; Kristensen JH; Harrison A; Andersen JL
    Scand J Urol Nephrol; 2007; 41(6):539-45. PubMed ID: 17853024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
    Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
    Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
    Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
    Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice.
    Raun SH; Ali MS; Han X; Henríquez-Olguín C; Pham TCP; Meneses-Valdés R; Knudsen JR; Willemsen ACH; Larsen S; Jensen TE; Langen R; Sylow L
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1631-1647. PubMed ID: 37194385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters.
    Mattson JP; Delp MD; Poole DC
    Eur Respir J; 2004 May; 23(5):703-7. PubMed ID: 15176683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy.
    Cortellini A; Palumbo P; Porzio G; Verna L; Giordano AV; Masciocchi C; Parisi A; Cannita K; Ficorella C; Bozzetti F
    Thorac Cancer; 2018 Dec; 9(12):1623-1630. PubMed ID: 30259689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
    Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
    Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
    de Jong C; Chargi N; Herder GJM; van Haarlem SWA; van der Meer F; van Lindert ASR; Ten Heuvel A; Brouwer J; de Jong PA; Devriese LA; Huitema ADR; Egberts TCG; de Bree R; Deneer VHM
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1554-1564. PubMed ID: 35301821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.
    Naito T; Okayama T; Aoyama T; Ohashi T; Masuda Y; Kimura M; Shiozaki H; Murakami H; Kenmotsu H; Taira T; Ono A; Wakuda K; Imai H; Oyakawa T; Ishii T; Omori S; Nakashima K; Endo M; Omae K; Mori K; Yamamoto N; Tanuma A; Takahashi T
    BMC Cancer; 2017 Aug; 17(1):571. PubMed ID: 28841858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.
    Goncalves MD; Taylor S; Halpenny DF; Schwitzer E; Gandelman S; Jackson J; Lukose A; Plodkowski AJ; Tan KS; Dunphy M; Jones LW; Downey RJ
    Clin Radiol; 2018 May; 73(5):505.e1-505.e8. PubMed ID: 29317048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patients.
    Dal Corso S; Nápolis L; Malaguti C; Gimenes AC; Albuquerque A; Nogueira CR; De Fuccio MB; Pereira RD; Bulle A; McFarlane N; Nery LE; Neder JA
    Respir Med; 2007 Jun; 101(6):1236-43. PubMed ID: 17174082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.